// App-Quantinova.ai

THU0628 (2017) : PATTERNS OF ETANERCEPT DOSE ADJUSTMENTS IN A REAL–WORLD SETTING: A CANADIAN RETROSPECTIVE COHORT STUDY

Researchers

Presenter

  • M. Khraishi

Principal Investigators

  • Y. Zhang

  • J. Ivanovic

  • B. Millson

  • E. Singh

  • J. Woolcott

  • H. Jones

Medical Centers

  • Faculty of Medicine, Memorial University of Newfoundland, St. Johns, NF, Canada

  • Health Access & Outcomes, QuintilesIMS, Kanata, Canada

  • Inflammation and Immunology, Global Medical Affairs, Pfizer Inc., Collegeville, United States

  • Health Economics and Outcomes Research, Pfizer Inc., Kirkland, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A